Renaissance Technologies’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-122,277	Closed	-$47K	–	4578
2022 Q2	$47K	Buy	122,277 +87,577	+252%	+$33.7K	﹤0.01%	4006
2022 Q1	$52K	Buy	+34,700	New	+$52K	﹤0.01%	3908